Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Phys Rev Lett. Author manuscript; available in PMC 2013 March 26.
Published in final edited form as:
PMCID: PMC3608271

Mechanical Activation of a Multimeric Adhesive Protein through Domain Conformational Change


The mechanical force-induced activation of the adhesive protein von Willebrand Factor (VWF), which experiences high hydrodynamic forces, is essential in initiating platelet adhesion. The importance of the mechanical force-induced functional change is manifested in the multimeric VWF’s crucial role in blood coagulation, when high fluid shear stress activates plasma VWF (pVWF) multimers to bind platelets. Here we showed that a pathological level of high shear stress exposure of pVWF multimers results in domain conformational changes, and the subsequent shifts in the unfolding force allow us to use force as a marker to track the dynamic states of multimeric VWF. We found that shear-activated pVWF multimers (spVWF) are more resistant to mechanical unfolding than non-sheared pVWF multimers, as indicated in the higher peak unfolding force. These results provide insight into the mechanism of shear-induced activation of pVWF multimers.

Von Willebrand factor (VWF) is a large multimeric protein constructed from two identical VWF monomers linked by C-terminal disulfide bonds into dimers, and the dimers then polymerize via N-terminal disulfide bonds into long VWF multimers [13]. The domain organization of a 250 kDa, 60 nm long VWF monomer [2, 4] is shown in Fig. 1(a). The largest VWF multimers contain up to 200 monomers [5] and are concentrated after synthesis in Weibel-Palade bodies and α-granules, the storage compartments of endothelial cells and platelets, respectively [2]. In response to stimulation by cytokines and other agents, these ultra-large VWF (ULVWF) multimers are rapidly secreted in long string-like structures by endothelial cells (ECs), where they are anchored [6]. EC-anchored ULVWF multimeric strings are hyper-adhesive in their capacity to bind platelet glycoprotein (GP) Ib-IX-V complexes [3, 7]. Circulating pVWF multimers are hemostatically inactive toward platelets, but can be activated by exposure to high shear stress [2, 8, 9]. It has been proposed that, under high shear stress, pVWF multimers undergo a change in conformation from a globular to an elongated form (quaternary structure change) [2, 911]. More recently, it has been demonstrated that shear-activated pVWF multimers become laterally apposed into fibrils via multimer-to-multimer disulfide bonds [12].

FIG. 1
Multimeric VWF unfolding with AFM. (a) The domain organization of a VWF monomeric subunit, where A1 is the platelet GP Ib-IX-V receptor binding domain, A2 contains the cleavage site for ADAMTS-13, and D3 contains the binding site for the subendothelial ...

The shear-induced conformational change exposes or alters the A1 domain in VWF monomeric subunits, enabling large VWF multimers to bind to platelet GP Ib-IX-V and initiate platelet adhesion and aggregation. The difference in the dynamic states of various forms of VWF multimers determines the on-off switching of VWF multimeric activation for platelet binding. In this study, we used single-molecule manipulation to monitor the force response of different forms of VWF multimers. The peak force was used as an indicator of the dynamic states of VWF monomeric subunit domains within VWF multimers.

We pulled single VWF multimeric molecules using an atomic force microscope (AFM) [Fig. 1(b)] (see Supplemental Material [13]). The sawtooth patterns of force peaks in the force-extension curves of pVWF multimers [Fig. 1(c), (d)] are characteristic of multi-domain protein unfolding (tertiary structure change) [1416]. The value of the peaks specifies the force required to unfold the domains, and is related linearly to the unfolding free energy barrier and logarithmically to the pulling speed [Fig. 2(a)] [1618]. The change in contour length (ΔLc) histogram of pVWF [Fig. 2(b)] shows a major peak at 30(8) nm. The values in the parentheses are one standard deviation. This is a typical length for an unfolded domain of 90 amino acid residues assuming 0.34 nm per residue [5, 19]. In addition, there was a minor peak at 60(15) nm, corresponding to an unfolded domain of 180 amino acid residues, consistent with domain unfolding.

FIG. 2
Unfolding of multimeric VWF. (a) Unfolding force as a function of pulling velocity for pVWF. The unfolding forces were binned by pulling velocity. The inset shows the binned histograms fitted with Gaussian curves. The peak of the the fitted Gaussian was ...

ULVWF multimers contain a larger number of monomers than pVWF, and are more active in adhering to platelets and inducing platelet aggregation [23]. We observed differences in peak unfolding forces at high pulling speeds between ULVWF and pVWF multimers [Fig. 2(c)], indicating that pVWF multimers and ULVWF are in different conformational states. Similarly, at high levels of shear stress (60–120 dyn/cm2), the capacity of pVWF multimers to adhere to, and aggregate to platelets increases as previously shown [23] and re-affirmed in this study (Supplemental Fig. 1). That is, spVWF become functionally similar to ULVWF multimers. The peak unfolding force of pVWF multimers increased after exposure to high shear stress, but the force-extension curves are qualitatively similar to unsheared pVWF multimers and unsheared ULVWF multimers. However, the reaction of pVWF to spVWF may not be 100%, and the shift in the peak force is a qualitative observation. The difference in the peak unfolding forces between pVWF multimers and either spVWF or ULVWF multimers was more pronounced at high pulling velocities [Fig. 2(c)]. This finding is compatible with the shear-induced conformational change in pVWF (to spVWF) that increases the exposure of platelet-binding A1 domains in the VWF monomeric subunits of spVWF multimers. It has been shown that exposure to a 100 dyn/cm2, high fluid shear stress induces pVWF multimers to associate laterally and form VWF fibrils that have an increased capacity to bind to platelet GPIbα [8]. This fibrillar state of laterally-associated VWF multimers may be the conformation of spVWF multimers that is functionally similar to ULVWF (Supplemental Fig. 2).

To measure the kinetics in spVWF force experiments, peak unfolding force measurements of pVWF were conducted at different delay times after shear exposure. The spVWF unfolding force decreased over time, and reached an equilibrium force after 10 hours [Figs. 3(a) and (b)]. Thus, the shear-induced change in pVWF to the spVWF multimeric conformation changes with time, with a prolonged relaxation time of several hours. Fitting the data to the exponential equation F(t) = Fp + (FsFp) exp(−t/τ), where Fs is the peak force immediately after shear exposure, Fp is the equilibrium peak force, and τ is the time constant, yields Fs = 180 pN, Fp = 130 pN, and τ = 3 hours. The difference in the peak unfolding force between spVWF or ULVWF multimers and pVWF multimers is more pronounced at high pulling velocity.

FIG. 3
Dynamics of VWF multimers. The data were taken at 1000 nm/s pulling velocity. (a) Peak force distributions of spVWF as a function of time since exposure to a pathological level of 100 dyn/cm2 fluid shear. (b) spVWF peak force decreases with time since ...

The force-extension curves showed that the unfolding force peaks correspond to the changes in the VWF multimeric conformation at the level of one or more domains within the VWF monomeric subunits. This conclusion is supported by i) the force-extension curves display a characteristic sawtooth pattern of repeated force peaks, resembling the known sequential unfolding of other multi-domain proteins [14]; ii) the increase in contour length after each peak, ΔLc, is 30 nm, which is comparable to the contour length of an unfolded domain or an intermediate state; and iii) at 1000 nm/s pulling velocity, the value of the peak unfolding force was distributed at 100–130 pN, and varied linearly with the natural logarithm of pulling velocity, as is typical of domain unfolding.

In addition, by stretching VWF dimers under similar conditions, we have observed up to four unfolding peaks per force-extension curve [Fig. 3(c)], suggesting that there are two unfolding events per monomer. The two force peaks can be from the unfolding of two different domains or from two partial domains. This conclusion is supported by when pulling eight serially linked titin I27 domain, (I27)8, up to eight unfolding peaks have been observed [14]. For comparison, pVWF curves have up to ten force peaks, suggesting that there are up to five monomers at a given pull. The number of peaks of ULVWF does not differ from pVWF or spVWF significantly, even though the ULVWF sample has more repeating units than pVWF [13]. Hence, it suggests a stronger interaction in ULVWF among monomers that may prevent the ULVWF polymer chain to be isolated to undergo domain unfolding. The dimer force peak and change in contour length, ΔLc, distributions are consistent with that of the multimer, further supporting the conclusion that the features in the multimeric VWF force-extension curves correspond to individual domain unfolding.

In the monomeric subunits of VWF multimers, the force peaks may be the combined result of unfolding of different domains. It is likely, however, that there is a major contributor to the force signal. A probable candidate is the VWF A2 domain, because it does not have disulfide bonds, and has been observed to unfold in the pico-newton force range [24, 25]. ΔLc of 60(15) nm determined from our experiment is similar to 57(5) nm observed by Zhang et al. [5]. The most frequent ΔLc observed, 30(8) nm, is consistent with the values reported in Zhang et al. [5], showing 40% of the unfolding peaks with ΔLc of 23(5) nm, which is attributed to partial unfolding of A2 [5, 24, 26]. The A1 and A3 domains contain disulfide bonds, which are unlikely to unfold during stretching experiments, because at a 100 nm/s pulling velocity, disulfide bonds typically rupture at 2 nN [27], a force much higher than the typical unfolding force (100–200 pN) observed in our study. Previous studies of the forced-unfolding of A1A2A3 triple domains also reveal that the VWF A2 domain can be partially or completely unfolded, possibly after inter-domain uncoupling [26, 28]. These findings suggest that the unfolding of a portion of the A2 domain in VWF monomeric subunits may be the main contributor to our unfolding force signals. We have ruled out that the change of unfolding force is simply due to more exposed A2 domains without intramolecular interactions, since such a configuration will only yield more unfolding peaks in a given pull [Fig. 3(c)], but not a significantly altered unfolding force [10, 17].

Our results suggest that high shear stress (100 dyn/cm2) converts spVWF multimers to a conformation that was metastable, probably due to the lateral association of spVWF multimers, with a long relaxation time. Over several hours, the metastable state of spVWF crossed the energy barrier and relaxes to a more stable state. Using the time constant τ = 3 hours determined from the relaxation curve shown in Fig. 3(b), we estimate the activation free energy barrier from spVWF to pVWF, using the Arrhenius equation, k = A exp(−ΔG/kBT), where k= 1/τ is the rate constant, ΔG is the free energy of barrier from spVWF to pVWF, and A is the pre-exponential factor. Assuming that A is between 105 s−1 and 1010 s−1, ΔG is 12–19 kcal/mol [2931]. The barrier height from an active state to an inactive state is comparable to protein unfolding, further supporting the notion of domain conformational changes for the observed force peak change.

Figure 4 highlights the free energy landscape [32] of different forms of VWF multimers. Our results suggest that pVWF multimers have different conformational states before and after shear exposure that unfold through different pathways (pathways 1 and 2). Proteins with multiple conformational states of different activities have been observed by force measurements [33]. Here, pVWF multimers are in a native, inactive state, but can be converted to a metastable, active state (spVWF) by exposure to high shear stress. This state may be considered ‘misfolded’ since it is a non-native state [34]. The spVWF multimer’s peak unfolding force, which is related to the barrier height [17, 35], is likely to be higher than that of pVWF multimers, because high shear stress induces the lateral association of several pVWF multimers into a fibrillar form spVWF multimers. Thus, shear effects on VWF monomeric A2 domains causes an associated increase in the exposure of platelet-binding VWF A1 domains.

FIG. 4
Free energy landscape of multimeric VWF. pVWF is the native, equilibrium state. Fast stretching of pVWF molecules results in domain unfolding (pathway 1), while the spVWF domain unfolds through a different pathway (pathway 2). High shear stress promotes ...

In summary, our results demonstrate that pVWF multimers have a different conformational state that unfold via a different pathway after exposure to high shear stress. pVWF is in a native, inactive state that can be converted to a metastable, active state, spVWF, by high shear stress. The peak unfolding force of spVWF multimers is higher than that of unsheared pVWF multimers, potentially because high shear stress induces the lateral association of pVWF multimers into a fibrillar form as indicated by the formation of large VWF aggregates after shear exposure. Thus, an increased intramolecular interaction shifts the domains to a different state that has a higher unfolding barrier. Shear-activated conformational changes in the A2 domains in VWF monomeric subunits of spVWF multimers may provoke an increased exposure of neighboring (platelet-binding) A1 domains. The effect decreases over several hours. It will be interesting to investigate if structural studies can resolve the two states and what external factors, whether physical, chemical, or biological, may affect the stability of and switching rate between these states.

Supplementary Material

Supplemental Material


We thank NIH HL71895 and HL85769 (J.F.D.); NSF 0907676, NIH GM008362, and Welch Foundation C-1632 (C.H.K.); the ANH (DOE/NASA), and NIGTP NIH Grant No. T32EB009379 (E.W.F.); the Mary R. Gibson Foundation and Everett Hinkson Fund (J.M.) for support.


1. Ruggeri ZM. Curr Opin Hematol. 2003;10:142. [PubMed]
2. Sadler JE. Annu Rev Biochem. 1998;67:395. [PubMed]
3. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. New Engl J Med. 1982;307:1432. [PubMed]
4. Fowler WE, Fretto LJ, Hamilton KK, Erickson HP, McKee PA. J Clin Invest. 1985;78:1491. [PMC free article] [PubMed]
5. Zhang X, Halvorsen K, Zhang C-Z, Wong WP, Springer TA. Science. 2009;324:1330. [PMC free article] [PubMed]
6. Li Y, Choi H, Nolasco L, Pownall HJ, Voorberg J, Moake JL, Dong J-F. J Thromb Haemost. 2008;6:1135. [PMC free article] [PubMed]
7. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, CNSL, McIntire V, Fujikawa K, Lopez JA. Blood. 2002;100:4033. [PubMed]
8. Choi H, Aboulfatova K, Pownall HJ, Cook R, Dong J-F. J Biol Chem. 2007;282:35604. [PubMed]
9. Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz RR, Schneider MF. Proc Natl Acad Sci USA. 2007;104:7899. [PubMed]
10. Siedlecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson DL, Marchant RE. Blood. 1996;88:2939. [PubMed]
11. Alexander-Katz A, Schneider MF, Schneider SW, Wixforth A, Netz RR. Phys Rev Lett. 2006;97:138101. [PubMed]
12. Yeh H-C, Zhou Z, Choi H, Tekeoglu S, WM, Wang C, Turner N, Scheiflinger F, Moake JL, Dong J-F. J Thromb Haemost. 2010;8:2778. [PMC free article] [PubMed]
13. See Supplemental Material for sample preparation and experimental methods.
14. Rief M, Gautel M, Oesterhelt F, Fernandez JM, Gaub HE. Science. 1997;276:1109. [PubMed]
15. Marszalek PE, Lu H, Li H, Carrion-Vazquez M, Oberhauser AF, Schulten K, Fernandez JM. Nature. 1999;402:100. [PubMed]
16. Carrion-Vazquez M, Oberhauser AF, Fowler SB, Marszalek PE, Broedel SE, Clarke J, Fernandez JM. Proc Natl Acad Sci USA. 1999;96:3694. [PubMed]
17. Harris NC, Song Y, Kiang C-H. Phys Rev Lett. 2007;99:068101. [PMC free article] [PubMed]
18. Harris NC, Kiang C-H. Phys Rev E. 2009;79:041912. [PubMed]
19. Oesterhelt F, Oesterhelt D, Pfeiffer M, Engel A, Gaub HE, Müller DJ. Science. 2000;288:143. [PubMed]
20. Bustamante C, Marko JF, Siggia ED, Smith S. Science. 1994;265:1599. [PubMed]
21. Onoa B, Dumont S, Liphardt J, Smith SB, Tinoco I, Jr, Bustamante C. Science. 2003;299:1892. [PMC free article] [PubMed]
22. Bakajin OB, Duke TAJ, Chou CF, Chan SS, Austin RH, Cox EC. Phys Rev Lett. 1998;80:2737.
23. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. J Clin Invest. 1986;78:1456. [PMC free article] [PubMed]
24. Baldauf C, Schneppenheim R, Stacklies W, Obser T, Pienconka A, Schneppenheim S, Budde U, Zhou J, Grater F. J Thromb Haemost. 2009;7:2096. [PubMed]
25. Jakobi AJ, Mashaghi A, Tans SJ, Huizinga EG. Nat Commun. 2011;2:385. [PMC free article] [PubMed]
26. Wu T, Lin J, Cruz MA, Dong J-F, Zhu C. Blood. 2010;115:370. [PubMed]
27. Iozzi MF, Helgaker T, Uggerud E. J Phys Chem A. 2011;115:2308. [PubMed]
28. Ying J, Ling Y, Westfield LA, Sadler JE, Shao J-Y. Biophys J. 2010;98:1685. [PubMed]
29. Popa I, Fernandez JM, Garcia Manyes S. J Biol Chem. 2011;286:31072. [PMC free article] [PubMed]
30. Mickler M, Hessling M, Ratzke C, Buchner J, Hugel T. Nat Struct Biol. 2009;16:281. [PubMed]
31. Yang WY, Gruebele M. Nature. 2003;423:193. [PubMed]
32. Onuchic JN, Luthey-Schulten Z, Wolynes PG. Annu Rev Phys Chem. 1997;48:545. [PubMed]
33. Gore J, Brant Z, Nollmann M, Le MU, Cozzarelli NR, Bustamante C. Nature. 2006;439:100. [PMC free article] [PubMed]
34. Sali A, Shakhnovich E, Karplus M. Nature. 1994;369:248. [PubMed]
35. Wuite GJL, Smith SB, Young M, Keller D, Bustamante C. Nature. 2000;404:103. [PubMed]